Stay updated with breaking news from Nasdaq tenx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Research analysts at Roth Capital lowered their FY2023 EPS estimates for Tenax Therapeutics in a report released on Thursday, February 15th. Roth Capital analyst J. Aschoff now expects that the specialty pharmaceutical company will earn ($26.55) per share for the year, down from their prior forecast of […] ....
Tenax Therapeutics (NASDAQ:TENX – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Roth Mkm in a report released on Tuesday, Benzinga reports. Separately, StockNews.com began coverage on Tenax Therapeutics in a research report on Wednesday, January 10th. They set a “sell” rating on the stock. Check Out Our Latest […] ....
Tenax Therapeutics (NASDAQ:TENX – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Roth Mkm in a report released on Tuesday, Benzinga reports. Separately, StockNews.com began coverage on Tenax Therapeutics in a research report on Wednesday, January 10th. They set a “sell” rating on the stock. Check Out Our Latest […] ....
Over 40 sites (U.S. and Canada) have agreed to participate in the LEVEL study LEVEL is a randomized, controlled Phase 3 trial of 152 patients, and will. ....
CHAPEL HILL, N.C., Feb. 08, 2024 (GLOBE NEWSWIRE) Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying,. ....